232 related articles for article (PubMed ID: 28528685)
21. Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron syndrome.
Shevah O; Laron Z
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():489-97. PubMed ID: 17551471
[TBL] [Abstract][Full Text] [Related]
22. Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome.
Al-Ashwal AA; Al-Sagheir A; Ramzan K; Al-Owain M; Allam R; Qari A; Al-Numair NS; Imtiaz F
Horm Res Paediatr; 2017; 88(2):119-126. PubMed ID: 28743110
[TBL] [Abstract][Full Text] [Related]
23. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?
Laron Z
Mech Ageing Dev; 2005 Feb; 126(2):305-7. PubMed ID: 15621211
[TBL] [Abstract][Full Text] [Related]
24. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations.
Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295
[TBL] [Abstract][Full Text] [Related]
26. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
27. Reporting a novel growth hormone receptor gene variant in an Iranian consanguineous pedigree with Laron syndrome: a case report.
Bitarafan F; Khodaeian M; Garrousi F; Khalesi R; Ghazi Nader D; Karimi B; Alibakhshi R; Garshasbi M
BMC Endocr Disord; 2023 Jul; 23(1):155. PubMed ID: 37474955
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
Somri L; Sarfstein R; Lapkina-Gendler L; Nagaraj K; Laron Z; Bach LA; Werner H
Growth Horm IGF Res; 2018 Apr; 39():6-12. PubMed ID: 29208357
[TBL] [Abstract][Full Text] [Related]
29. Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model.
Laron Z
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():188-91. PubMed ID: 16641857
[TBL] [Abstract][Full Text] [Related]
30. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report.
Laron Z; Ginsberg S; Webb M
Growth Horm IGF Res; 2008 Oct; 18(5):434-438. PubMed ID: 18462969
[TBL] [Abstract][Full Text] [Related]
32. Comparative skeletal features between Homo floresiensis and patients with primary growth hormone insensitivity (Laron Syndrome).
Hershkovitz I; Kornreich L; Laron Z
Am J Phys Anthropol; 2007 Oct; 134(2):198-208. PubMed ID: 17596857
[TBL] [Abstract][Full Text] [Related]
33. Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndrome.
Laron Z; Werner H
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37343154
[TBL] [Abstract][Full Text] [Related]
34. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
36. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups.
Shevah O; Rubinstein M; Laron Z
Isr Med Assoc J; 2004 Oct; 6(10):630-3. PubMed ID: 15473594
[TBL] [Abstract][Full Text] [Related]
37. Identification of signaling pathways associated with cancer protection in Laron syndrome.
Lapkina-Gendler L; Rotem I; Pasmanik-Chor M; Gurwitz D; Sarfstein R; Laron Z; Werner H
Endocr Relat Cancer; 2016 May; 23(5):399-410. PubMed ID: 27090428
[TBL] [Abstract][Full Text] [Related]
38. Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment - A pilot study.
Barazani C; Werner H; Laron Z
Growth Horm IGF Res; 2020 Jun; 52():101312. PubMed ID: 32200226
[TBL] [Abstract][Full Text] [Related]
39. Generation of a miniature pig disease model for human Laron syndrome.
Cui D; Li F; Li Q; Li J; Zhao Y; Hu X; Zhang R; Li N
Sci Rep; 2015 Oct; 5():15603. PubMed ID: 26511035
[TBL] [Abstract][Full Text] [Related]
40. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.
Steuerman R; Shevah O; Laron Z
Eur J Endocrinol; 2011 Apr; 164(4):485-9. PubMed ID: 21292919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]